Washington, DC, United States of America

Jesus V Soriano


Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jesus V Soriano in Cancer Treatment

Introduction

Jesus V Soriano is a notable inventor based in Washington, DC, who has made significant contributions to the field of cancer research. He holds 2 patents that focus on innovative methods for inhibiting cell motility and angiogenesis, which are critical processes in cancer progression.

Latest Patents

His latest patents include methods for inhibiting cell motility, angiogenesis, and metastasis. These patents disclose techniques for inhibiting the binding between intracellular transducers and receptor protein tyrosine kinases, particularly focusing on hepatocyte growth factor (HGF) induced cell motility. The inventions also provide methods for preventing and treating various diseases, including metastatic cancers such as melanoma and prostate cancer, by administering specific peptides. Additionally, his patents describe methods for blocking HGF, VEGF, or bFGF-stimulated migration, cell proliferation, and the formation of capillary-like structures.

Career Highlights

Jesus V Soriano is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution underscores his commitment to advancing medical research and developing innovative treatments for cancer.

Collaborations

He has collaborated with notable colleagues, including Donald P Bottaro and Safiye N Atabey, to further enhance the impact of his research and inventions.

Conclusion

Jesus V Soriano's contributions to cancer research through his innovative patents highlight the importance of scientific advancements in the fight against cancer. His work continues to inspire future research and development in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…